硕通镜联合钬激光治疗肾盂结石的临床疗效.

Objective To investigate the efficacy of Shuotong Jing combined with holmium laser in the treatment of renal pelvis. Methods Sixty- six patients with pyelonesis treated with Shuotong Jing combined with holmium laser and 76 patients with ureteral calculi treated with ureteroscope and holmium laser were selected from the urinary ward of the Second Affiliated Hospital of KunmingMedical University from January to September 2018. In the Shuotong group，there were 34 males and 30 females， aged 23- 64 years old， with an average of （41.09±7.11） years old，with a diameter of 0.8- 2.0 cm，an average of 1.2 cm. And there were 40 males in the ureteroscopy group， 36 female，aged 25 to 68 years，mean （43.38 ± 7.81） years old， stone diameter of 0.7 ~ 2.0cm， an average of 1.1cm. All patients underwent general anesthesia， and then placed under the guidance of super- sliding black guide wire，then enter the Shuotong Jing and ureteroscope to find the renal calculus，and crush the stone. We observed the operation time， hospital stay， intraoperative bleeding， stone clearance rate （January）， postoperative complications， success rate of sheathing and other related conditions. Results The operation time of the Shuotong group was 60.84±10.27min， the average intraoperative blood loss was 27.98ml， the stone clearance rate was （16.87%） （62/64）， and the postoperative complications were 4.68% （3/64） . The ureter was soft. The average operation time of the microscope group was 75.05±8.61min， the average intraoperative blood loss was 54.71ml， the stone clearance rate （January） was 78.94% （62/64）， and the postoperative complications were 21.05% （3/64. There were significant differences in operation time， intraoperative bleeding， stone clearance rate， and postoperative complications between the two groups （P < 0.05）， but there was no significant difference in hospitalization time and catheterization success rate（P > 0.05） . Conclusion Shuotong Jing lithotripsy has the advantages of feasibility， relative safety， high stone removal rate and lowinfection rate in the treatment of renal pelvis. [ABSTRACT FROM AUTHOR]